However, a more detailed analysis of tau pathology based on Braak NFT and BrainNet staging (see below) showed that stages increase with ageing amongst those without dementia,46 consistent with observations showing that tau pathology increases with age47; however, in CFAS this increase was not seen in those with dementia. The gene discussed is MAPT; the disease is dementia.